Related references
Note: Only part of the references are listed.Guillain-Barre syndrome and Fisher syndrome: Case definitions and guidelines for collection, analysis, and presentation of immunization safety data
James J. Sejvar et al.
VACCINE (2011)
Near Real-Time Surveillance for Influenza Vaccine Safety: Proof-of-Concept in the Vaccine Safety Datalink Project
Sharon K. Greene et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2010)
Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010
Claudia Vellozzi et al.
VACCINE (2010)
Randomized, Double-Blind Controlled Phase 3 Trial Comparing the Immunogenicity of High-Dose and Standard-Dose Influenza Vaccine in Adults 65 Years of Age and Older
Ann R. Falsey et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines
Steven Black et al.
LANCET (2009)
Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons
Wendy A. Keitel et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Understanding vaccine safety information from the vaccine adverse event reporting system
F Varricchio et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2004)
Recurrence risk of oculorespiratory syndrome after influenza vaccination
G De Serres et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the USFDA's spontaneous reports database
A Szarfman et al.
DRUG SAFETY (2002)
Share Paper
